Literature DB >> 9270793

Prevention of rejection with BTI-322 after renal transplantation (results at 9 months).

T Besse1, J Malaise, M Mourad, Y Pirson, J Hope, M Awwad, M White-Scharf, J P Squifflet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9270793     DOI： 10.1016/s0041-1345(97)00432-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.

Authors:  Maria Iglesias-Ussel; Claire Vandergeeten; Luigi Marchionni; Nicolas Chomont; Fabio Romerio
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

2.  Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study.

Authors:  Erik Berglund; Paula Alonso-Guallart; Makenzie Danton; Felix Sellberg; Christian Binder; Robin Fröbom; David Berglund; Nathaly Llore; Hiroshi Sakai; Alina Iuga; Dilrukshi Ekanayake-Alper; Keith A Reimann; David H Sachs; Megan Sykes; Adam Griesemer
Journal:  Transpl Int       Date:  2019-11-15       Impact factor: 3.842
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.